Sensei Biotherapeutics (SNSE) Appoints Kristian Humer to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Sensei Biotherapeutics (SNSE) Appoints Kristian Humer to its Board

Sensei Biotherapeutics Appoints Kristian Humer to its Board of Directors

August 2, 2021 8:01 AM EDT

BOSTON, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of Kristian Humer, former managing director of Banking, Capital Markets & Advisory for the Global Healthcare team at Citigroup, Inc. as an independent director to the companys board of directors, effective July 30, 2021.

Mr. Humer is currently chief financial officer and chief business officer of Viridian Therapeutics, which he joined in July 2021 after 11 years with Citigroup where he helped lead... More